Reversal of Doxorubicin-Induced Bone Loss and Mineralization by Supplementation of Resveratrol and MitoTEMPO in the Early Development of Sparus aurata

Doxorubicin is a widely used chemotherapeutic drug known to induce bone loss. The mechanism behind doxorubicin-mediated bone loss is unclear, but oxidative stress has been suggested as a potential cause. Antioxidants that can counteract the toxic effect of doxorubicin on the bone would be helpful fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Poudel, Sunil, Izquierdo, Marisol, Cancela, Maria Leonor, Gavaia, Paulo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950850/
https://www.ncbi.nlm.nih.gov/pubmed/35334811
http://dx.doi.org/10.3390/nu14061154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950850/
https://www.ncbi.nlm.nih.gov/pubmed/35334811
http://dx.doi.org/10.3390/nu14061154

Ejemplares similares